Pharmaceutical companies are betting big on a new wave of innovative cancer therapies they believe will be more effective than existing treatments and move them a big step closer to finding a cure for the disease.

The fast-emerging branch of therapies – immuno-oncology (IO) – works by equipping the body’s immune system with the tools to kill cancer cells.

University of Maryland's Center for Environmental Science

The Old Line's flag laid board-flat against the marbled gray sky as crisply as if it had been pressed by a hot iron. I double checked my lifejacket, clipped the boat's kill switch onto its nylon strap and eased the 25-foot center console beyond the breakwaters of Matapeake. White caps that had rolled past Point Lookout three hours earlier continued to barrel northward toward Rock Hall. I took a quick look around, briefly questioned my decision-making faculties and then punched the throttle to get on top of the rumbling three footers.


The Small Business Innovation Research and Small Business Technology Transfer Improvements Act of 2017, H.R. 2763, unanimously passed a House committee last week, moving one step closer to approval.

“The bill ultimately helps small businesses advance innovation and research that will help industries across California and the nation,” Knight said. “The advantages of supporting small business in their ventures are endless as some of the greatest entrepreneurial developments in technology originate from the support of the surrounding community and government resources.”


Nearly two years after its launch, Johnson & Johnson’s crowdfunding website for global public health projects in underserved communities has raised almost $500,000 for 51 projects to date.

The percentage of projects posted on the website that are funded has increased from 33 percent one year ago to 65 percent this year, according to an email from Fetzer.


Innovations born in the world of academia have contributed more than a trillion dollars to the US economy over the past two decades, according to a new report.

Examining the licensing of university technology, a study undertaken by the Biotechnology Innovation Organization (BIO) and the Association of University Technology Managers (AUTM), reveals that over a 20 year period  ‘academic patents and the subsequent licensing to industry’ boosted industry output by $1.33 trillion.


GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the closing of its underwritten public offering of 8,050,000 shares of its common stock at a public offering price of $11.50 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,050,000 additional shares of common stock. All of the shares in the offering were offered by GlycoMimetics. The aggregate gross proceeds to GlycoMimetics from the offering, before deducting the underwriting discounts and commissions and offering expenses, were approximately $92.6 million.


Switzerland, Sweden, the Netherlands, U.S. and UK are the world's most innovative countries according to a new report by produced by Cornell University, INSEAD and the World Intellectual Property Organization (WIPO).

Now in its 10 edition, the Global Innovation Index surveys 130 economies using dozens of metrics - from patent filings to education spending - for a high-level look at the innovative activity that increasingly drives economic and social growth.


Over the past four years, 1,668 deals involving university spinout companies from across the globe attracted approximately $35.6 billion from 2013 to 2016, according to a new report from Global University Venturing. The report, however, highlights that global deals peaked in 2014 with 529 deals and total investments dollars peaked in 2015 with nearly $14 billion invested. As the authors highlighted, these global numbers were unsustainable and 2016 saw significant declines in both deals and dollars. In 2016, the total deals reported were 407 (21.6 percent decrease from 2015) and dollars invested was $6.4 billion (a 54.3 percent decrease from 2015).


The brain continues to surprise us with its magnificent complexity. Groundbreaking research that combines neuroscience with math tells us that our brain creates neural structures with up to 11 dimensions when it processes information. By "dimensions," they mean abstract mathematical spaces, not other physical realms. Still, the researchers "found a world that we had never imagined," said Henry Markram, director of the Blue Brain Project, which made the discovery.


The Maryland Department of Commerce and bwtech@UMBC Research & Technology Park today announced the establishment of an international cybersecurity center, iCyberCenter@bwtech. The governor made the announcement in an address to cyber industry leaders and officials at the Houses of Parliament in London during the administration’s economic development and trade mission to Europe.


In Uganda alone, nearly 600,000 newborns require medical intervention for complications at birth. That's a problem that Teresa Cauvel and Sona Shah are on a mission to solve. Neopenda, the health tech startup they founded in 2015, makes wearables that monitor four newborn vitals: Heart rate, respiration, blood oxygen saturation, and temperature.